397 related articles for article (PubMed ID: 15171447)
1. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
Higashikata T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447
[No Abstract] [Full Text] [Related]
2. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
Kotake H; Oikawa S
Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
[No Abstract] [Full Text] [Related]
3. [What other effects do statins have except their effect on lipids?].
Tikkanen MJ
Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
[No Abstract] [Full Text] [Related]
4. [Hyperlipidemia in patients with ischemic heart disease].
Murase T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():722-7. PubMed ID: 11347161
[No Abstract] [Full Text] [Related]
5. Statins, low cholesterol, and hemorrhagic stroke: an uncertain triangle.
Jacobs BS; Greenberg SM
Neurology; 2008 Jun; 70(24 Pt 2):2355-6. PubMed ID: 18541869
[No Abstract] [Full Text] [Related]
6. [Gemfibrozil: new aspects in clinical use].
Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
[No Abstract] [Full Text] [Related]
7. [Overviews of fibrate].
Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
[No Abstract] [Full Text] [Related]
8. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
Idzior-WaluĊ B
Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
[TBL] [Abstract][Full Text] [Related]
9. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
[No Abstract] [Full Text] [Related]
10. [Treatment with statins: lowering of cholesterol or more?].
Rutishauser J
Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
[No Abstract] [Full Text] [Related]
11. [Statins (HMG-CoA reductase inhibitors)].
Gotoda T
Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
[TBL] [Abstract][Full Text] [Related]
12. Summary of the role of statins in the treatment of dyslipidemia.
Carr LL
J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S1-3. PubMed ID: 12884937
[No Abstract] [Full Text] [Related]
13. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
Packard C
Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
[TBL] [Abstract][Full Text] [Related]
14. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
Balbisi EA
Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
[TBL] [Abstract][Full Text] [Related]
15. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
[TBL] [Abstract][Full Text] [Related]
16. Review of efficacy of rosuvastatin 5 mg.
Teramoto T; Watkins C
Int J Clin Pract; 2005 Jan; 59(1):92-101. PubMed ID: 15707472
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidaemia and cardiovascular disease.
Sussekov AV
Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
[No Abstract] [Full Text] [Related]
18. [ALLHAT].
Ando K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
[No Abstract] [Full Text] [Related]
19. [Clinical feature and treatment of the hyperlipidemia in the elderly].
Ito H
Nihon Rinsho; 2001 Mar; 59 Suppl 3():758-65. PubMed ID: 11347169
[No Abstract] [Full Text] [Related]
20. [Treatment of hyperlipidemia].
Yoshino G
Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
